Himalaya Bresol Syrup is a potent remedy for concerns associated with respiratory. Its key ingredients include holy basil, malabar nut, and turmeric, each offering unique benefits. Turmeric contains curcumin, which helps block proteins associated with allergies and asthma. Holy basil boasts antihistaminic and antioxidant properties, while Malabar Nut acts as a mucolytic, aiding in mucus thinning and cough relief. This syrup is particularly effective for managing concerns related to allergic rhinitis, allergic bronchitis, bronchial asthma, and pollen allergies.
“ARJUNA HIMALAYA” has been added to your cart. View cart
-10%

Himalaya Bonnispaz Drop
₹75.00 Original price was: ₹75.00.₹67.00Current price is: ₹67.00.

Himalaya Bresol Tablet for Respiratory Health | Manages Allergic Rhinitis & Bronchitis
₹220.00 Original price was: ₹220.00.₹198.00Current price is: ₹198.00.
Himalaya Bresol Syrup for Respiratory Health
₹180.00 Original price was: ₹180.00.₹162.00Current price is: ₹162.00.
- Made with ayurvedic ingredients
- Supports the working of respiratory system
- Improves breathing and reduces allergies
Categories: Diabetic Care, Elderly Care, Healthcare, Liver Care, Respiratory Care
Description
Reviews (0)
Be the first to review “Himalaya Bresol Syrup for Respiratory Health” Cancel reply
Related products
ARJUNA HIMALAYA
Baidyanath (Jhansi) Vridhiwadhika Bati
Baidyanath (Jhansi) Yakuti Ras with Gold Pearl & Kesar
Dabur Amritarishta Syrup
The key ingredient Amrutha is known for its dosha-balancing properties and may help nourish the body tissues particularly (rasa and rakta dhatus)
The presence of Dashamoola (group of 10 roots) and Trikatu (dry ginger – pepper – long pepper) in this formulation may act on inflammatory conditions and the digestive system respectively
The formulation may also help to provide comfort in case of associated body aches and swollen joints
Ingredients like Trikatu and Musta improve digestion while Indrayava, Parpataka etc. help ama dosha (accumulated toxins) from the body
Reviews
There are no reviews yet.